Ischemia Using Sandboxaq Magnetocardiography Device (PRISM)

Overview

About this study

The purpose of this is to characterize the relationship between pre-procedural MCG-based, and the peri-procedural angiography-based measures. The quantitative angiographic measures may include the location(s) and extent of stenosis, TIMI flow grade, OMI vs. NOMI determination.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years on the date of consent.
  • Scheduled to undergo a diagnostic angiography or revascularization procedure for the diagnosis or treatment of ischemia or acute myocardial infarction.
  • Ability for participant to comply with study requirements.
  • Patient consented at least 45 minutes before the planned, clinically indicated cath-lab procedure begins to allow sufficient time for study related activities.
  • Written informed consent.

Exclusion Criteria:

  • Present STEMI.
  • Pregnant or breastfeeding.
  • Active thoracic metal implants (including pacemaker, insertable cardiac monitor, or internal defibrillator)
  • External electrical pads or devices (e.g. Pacer pads, ECG electrodes, heart rate patch), that must remain on patient’s chest during MCG scan.
  • Inability to lie down in a supine/inclined position and stay still on the examination bed for up to 15 minutes.
  • Poor access to follow-up (e.g. no phone)
  • Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/17/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Adnan Alkhouli, M.D., M.B.A.

Open for enrollment

Contact information:

Ghasaq Saleh M.D.

(507) 266-0869

Saleh.Ghasaq@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20571516

Mayo Clinic Footer